Evidence map›Paper›PMID 37728651›Full record

ArticleWiener klinische Wochenschrift2023

[Diagnosis and therapy of granulomatosis with polyangiitis and microscopic polyangiitis-2023: consensus of the Austrian society of nephrology (ÖGN) and Austrian society of rheumatology (ÖGR)].

Balazs Odler, Martin Windpessl, Kathrin Eller, Marcus D Säemann, Karl Lhotta, Irmgard Neumann, Gregor Öberseder, Christina Duftner, Christian Dejaco, Michael Rudnicki and 5 more

Open access · hybridAbstract readEnglish AbstractConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Wiener klinische Wochenschrift, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 3 countries.

Balazs OdlerKlinische Abteilung für Nephrologie, Abteilung für Innere Medizin III (Nephrologie, Dialyse und Hypertensiologie), Medizinische Universität Graz, Graz, Österreich.
Martin WindpesslAbteilung für Innere Medizin IV, Klinikum Wels-Grieskirchen, Wels, Österreich.
Kathrin EllerKlinische Abteilung für Nephrologie, Abteilung für Innere Medizin III (Nephrologie, Dialyse und Hypertensiologie), Medizinische Universität Graz, Graz, Österreich.
Marcus D Säemann6. Medizinische Abteilung mit Nephrologie & Dialyse, Klinik Ottakring, Wien, Österreich.
Karl LhottaAbteilung für Innere Medizin III (Nephrologie, Dialyse und Hypertensiologie), Akademisches Lehrkrankenhaus Feldkirch, Feldkirch, Österreich.
Irmgard NeumannVasculitis.at, Wien, Österreich.
Gregor ÖbersederInnere Medizin, Wien, Österreich.
Christina DuftnerDepartment Innere Medizin II, Medizinische Universität Innsbruck, Innsbruck, Österreich.
Christian DejacoRheumatologie, Krankenhaus Bruneck, Bruneck, Italien.
Michael RudnickiDepartment Innere Medizin IV (Nephrologie und Hypertensiologie), Medizinische Universität Innsbruck, Innsbruck, Österreich.
Philipp GaucklerDepartment Innere Medizin IV (Nephrologie und Hypertensiologie), Medizinische Universität Innsbruck, Innsbruck, Österreich.
Rainer HintenbergerAbteilung Innere Medizin 2 (Gastroenterologie und Hepatologie, Endokrinologie und Stoffwechsel, Nephrologie, Rheumatologie), JKU, Linz, Österreich.
Jochen Zwerina1. Medizinische Abteilung, Hanusch Krankenhaus, Wien, Österreich.
Jens ThielKlinische Abteilung für Rheumatologie und Immunologie, Bereich Innere Medizin, Medizinische Universität Graz, Graz, Österreich.
Andreas KronbichlerDepartment Innere Medizin IV (Nephrologie und Hypertensiologie), Medizinische Universität Innsbruck, Innsbruck, Österreich. andreas.kronbichler@i-med.ac.at.
Innsbruck Medical University · ATMedical University of Graz · ATHanusch Hospital · ATImmunologie-Zentrum Zürich · CHKlinikum Wels-Grieskirchen · ATKrankenhaus Bruneck · ITLandeskrankenhaus Feldkirch · ATUniversitätszahnklinik Wien · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ANCA-associated vasculitides (AAV) are rare, complex systemic diseases that are often difficult to diagnose, because of unspecific clinical symptoms at presentation. However, the clinical course may be very dramatic and even life-threatening, necessitating prompt diagnosis and treatment.Therefore, it is important to increase disease awareness among physicians and support colleagues who are not confronted with these rare diseases on a regular basis. Here, the Austrian Society of Nephrology (ÖGN) and the Austrian Society of Rheumatology (ÖGR) provide a joint consensus on how to best diagnose and manage patients with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA).

Indexed as

Granulomatosis with PolyangiitisMicroscopic PolyangiitisNephrologyRheumatologyAustriaHumansIntercellular Signaling Peptides and ProteinsIntercellular Signaling Peptides and ProteinsOGN protein, humanANCA-associated vasculitides (AAV)AvacopanDiagnosticsRituximabTherapy

Identifiers

PMID37728651
PMCPMC10511611
OpenAlexW4386878163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.